News
23 June 2015

NCI Funding Opportunity Announcement: Smoking Cessation within the Context of Lung Cancer Screening

Research Project Grant

The goal of this Funding Opportunity Announcement is to improve the effectiveness and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening. The proposed projects must be aimed at determining:

a) the key components and characteristics of an effective smoking cessation intervention delivered in the LDCT setting; and/or

b) characteristics of an implementation strategy to optimally incorporate existing evidence-based smoking cessation intervention(s) into the LDCT setting.

The projects must include prospective, comparative evaluation of the intervention(s) in terms of the rates of cessation and sustained abstinence (6-12 months after cessation) among current smokers undergoing screening. The LDCT screening site must be the essential context for the delivery of the cessation intervention, although interventions may also include services provided outside the site before or after screening.

This project is led by the National Institutes of Health (NIH) and the National Cancer Institute (NCI).

Letter of Intent Due Date: September 8, 2015

Application Due Date: October 8, 2015, by 5:00 PM local time of applicant organisation.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

For more information, requirements, or to apply: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-011.html

Related content

Elderly couple eating watermelon symbolising a healthier lifestyle through nutrition

Three international collaborations funded by the UICC-led Reimagining Cancer Research in Europe initiative will explore how to improve the uptake and implementation of effective cancer prevention strategies in diverse health system settings.

Hand of a Radiologist showing tomography scan of a patient's lungs with blurry CT machine with patient in the background

Marking World Lung Cancer Awareness Day on 1 August, Catharine Grimes, President of the Bristol Myers Squibb Foundation (BMS Foundation), explains how the Foundation is helping health systems in low- and middle-income countries build the capacity to detect and treat lung cancer earlier.